Chimeric Therapeutics Limited (CHM.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 7.45 Million AUD | 110.54% |
| 2023 | 3.54 Million AUD | 112.33% |
| 2022 | 1.66 Million AUD | 297.48% |
| 2021 | -844.31 Thousand AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -1.75 Million AUD | -135.14% |
| 2024 FY | -3922.00 AUD | -100.11% |
| 2024 Q2 | 4.99 Million AUD | -8.87% |
| 2024 Q1 | 5.48 Million AUD | 677.15% |
| 2024 Q4 | -2.23 Million AUD | -27.41% |
| 2023 Q1 | 1.5 Million AUD | 15.01% |
| 2023 Q2 | 1.5 Million AUD | 0.0% |
| 2023 Q4 | 705.81 Thousand AUD | 0.0% |
| 2023 Q3 | 705.81 Thousand AUD | -53.1% |
| 2023 FY | 3.54 Million AUD | 112.33% |
| 2022 Q4 | 1.3 Million AUD | 0.0% |
| 2022 Q3 | 1.3 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2022 FY | 1.66 Million AUD | 297.48% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | -844.31 Thousand AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 85.369% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 1095.278% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -72378.958% |
| Biome Australia Limited | 7.66 Million AUD | 2.815% |
| Patrys Limited | 1.39 Million AUD | -434.639% |
| Orthocell Limited | 3.68 Million AUD | -102.085% |
| Imugene Limited | -5.83 Million AUD | 227.636% |
| Noxopharm Limited | -534.81 Thousand AUD | 1493.714% |
| PYC Therapeutics Limited | 22.05 Million AUD | 66.21% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -100.781% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 763.623% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -221.886% |
| CSL Limited | 15.28 Billion AUD | 99.951% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 28791.389% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 2572.636% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 90.456% |
| Starpharma Holdings Limited | 7.65 Million AUD | 2.655% |
| Nanollose Limited | -348.95 Thousand AUD | 2236.035% |
| Memphasys Limited | 1606.00 AUD | -464018.057% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -514.865% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 8260.697% |
| Amplia Therapeutics Limited | 4.01 Million AUD | -85.844% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 213.771% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -495.548% |
| Race Oncology Limited | 1.38 Million AUD | -436.273% |
| Nyrada Inc. | -5164.07 AUD | 144438.4% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 97.584% |
| Dimerix Limited | 583.47 Thousand AUD | -1177.467% |
| PharmAust Limited | -1641.00 AUD | 454319.135% |
| Immutep Limited | 1.44 Million AUD | -416.221% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 35.222% |
| Alterity Therapeutics Limited | 3.8 Million AUD | -95.894% |
| BTC Health Limited | 16.36 Thousand AUD | -45460.733% |
| Acrux Limited | -1.28 Million AUD | 680.509% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 96.367% |
| Biotron Limited | -40.49 Thousand AUD | 18505.195% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -4852.287% |
| AdAlta Limited | 1.5 Million AUD | -394.307% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 134.981% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -1518.98% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -13020.003% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 2132.275% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 17119.605% |
| Actinogen Medical Limited | 9.93 Million AUD | 24.949% |
| Immuron Limited | 3.33 Million AUD | -123.38% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -186.91% |